Department of Anesthesiology, Chengdu Women's and Children's Central Hospital, Chengdu, China.
Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China -
Minerva Anestesiol. 2022 Jan-Feb;88(1-2):62-71. doi: 10.23736/S0375-9393.21.15807-9. Epub 2021 Oct 28.
Recent years have witnessed the rapid expansion of quadratus lumborum block (QLB) technique in laparoscopic surgeries. However, inconsistent conclusions from latest studies prompted us to conduct present study to evaluate comprehensively the effects of QLB in patients undergoing laparoscopic surgery.
Databases including PubMed, Embase, and Cochrane Library were searched from inception to March 2021 by us. Randomized controlled trials comparing QLB versus placebo or different block techniques were involved. Co-primary outcomes included number of patients requiring additional analgesia, opioids consumption and incidence of postoperative nausea/vomiting (PONV).
Data from 20 studies involving a total of 1,332 patients were acquired. Based on the current evidences, the results indicated that application of QLB was associated with less number of patients requiring additional analgesia (RR=0.67, with 95% CI [0.49, 0.91]), reduced intraoperative opioid consumption (SMD -0.97 with 95% CI [-1.48, -0.45]) and postoperative opioid consumption (SMD -19.12 with 95% CI [-34.83, -3.41]), and less incidence of postoperative nausea and vomiting (RR=0.71, with 95% CI [0.58, 0.87]) compared to placebo. In addition, no significant intergroup (QLB vs. different regional block techniques) differences were observed for most outcomes.
Current evidence exhibited several superiorities of QLB for patients in laparoscopic surgeries. Differences between QLB and some other block techniques in analgesic effects and PONV controlling effects were not significant. However, it calls for more high-quality evidence with large samples and trials with consistent evaluation scales for pain evaluation to draw more reliable conclusions.
近年来,腹横肌平面阻滞(QLB)技术在腹腔镜手术中的应用迅速扩大。然而,最近的研究结果不一致,促使我们进行本研究,以全面评估 QLB 在腹腔镜手术患者中的效果。
我们从成立到 2021 年 3 月,在 PubMed、Embase 和 Cochrane Library 等数据库中进行了搜索。纳入了比较 QLB 与安慰剂或不同阻滞技术的随机对照试验。主要结局包括需要额外镇痛的患者人数、阿片类药物的消耗和术后恶心/呕吐(PONV)的发生率。
我们获得了 20 项研究的数据,共涉及 1332 名患者。根据目前的证据,结果表明应用 QLB 与需要额外镇痛的患者人数减少相关(RR=0.67,95%CI[0.49,0.91])、术中阿片类药物消耗减少(SMD-0.97,95%CI[-1.48,-0.45])和术后阿片类药物消耗减少(SMD-19.12,95%CI[-34.83,-0.31])以及术后恶心和呕吐的发生率降低(RR=0.71,95%CI[0.58,0.87])与安慰剂相比。此外,对于大多数结局,QLB 与不同的区域阻滞技术之间没有观察到显著的组间差异。
目前的证据显示 QLB 在腹腔镜手术中对患者具有几个优势。QLB 在镇痛效果和 PONV 控制效果方面与其他一些阻滞技术之间的差异并不显著。然而,需要更多高质量的证据,包括大样本和使用一致的疼痛评估评估标准的试验,以得出更可靠的结论。